D-0870-2023 Class III Terminated

Recalled by HF Acquisition Co LLC — Mukilteo, WA

FDA drug recall D-0870-2023 was initiated by HF Acquisition Co LLC on Jun 6, 2023 and is designated Class III. Reason for recall: Labeling: Label Mix-up The recall status is terminated (terminated Feb 27, 2024). Affected quantity: 9 boxes of 25 vials.

Recall Details

Product Type
Drugs
Report Date
Jun 14, 2023
Initiation Date
Jun 6, 2023
Termination Date
Feb 27, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
9 boxes of 25 vials

Product Description

GLYCOPYRROLATE INJECTION, USP 0.2MG/ML, 1mL VIAL, manufactured by HF Acquisition Co. LLC, Mukilteo, WA 98275, NDC 51662-1487-3

Reason for Recall

Labeling: Label Mix-up

Distribution Pattern

Distributed in TX, AZ and CA only

Code Information

Lot #: 2205095.1, Exp. Date 7/31/2024

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0870-2023
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0870-2023. Report a data issue: hello@regdatalab.com.